Although the identification of conolidine as a possible novel analgesic agent provides yet another avenue to address the opioid disaster and regulate CNCP, even more studies are needed to understand its mechanism of motion and utility and efficacy in managing CNCP.Conolidine isn’t only a passing trend in ache relief—it’s a potential match-cha